Biotech Business - November 5, 2025
Neogap launches collaboration with Weill Cornell Medicine
Neogap Therapeutics has been awarded a SEK 1 million grant from Vinnova to initiate a collaborative project with Weill Cornell Medicine in New York, US.
New Market - November 5, 2025
Moberg Pharma and Karo Healthcare in license agreement
Moberg Pharma has entered into an exclusive licensing agreement with Karo Healthcare regarding the commercialization of MOB-015 (Terclara) in Europe.
Clinical Trials - November 4, 2025
ScandiBio initiates Phase 3 trial: Mini-interview with Mathias Uhlén
The multicentre, phase 3 human clinical trial will evaluate the efficacy and safety of the company's pharmaceutical, Combined Metabolic Activator, in patients with Alzheimer's disease.
Biotech Business - November 3, 2025
Alvotech provides disappointing update on US BLA for AVT05
The FDA has issued a complete response letter (CRL) for Alvotech’s Biologics License Application (BLA) for AVT05, in a prefilled syringe and autoinjector presentations, a biosimilar candidate to Simponi (golimumab).
Global report - November 3, 2025
Pfizer files lawsuit against Metsera and Novo Nordisk for breach of merger agreement
Pfizer has filed a lawsuit against Metsera, its Board of Directors, and Novo Nordisk, in the Delaware Court of Chancery.
Denmark - November 3, 2025
BOOST Pharma adds Sound Bioventures to investor syndicate
Sound Bioventures has joined the company's investor syndicate with a SEK 34 million investment.
